Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-12-19

Clinical Trial Update: Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase II trial evaluating the FOLFOXIRI chemotherapy regimen in locally advanced or metastatic biliary tract cancer is ongoing, with the current status listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Irinotecan (Irinotecan)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Soon Chun Hyang University | Conditions: Biliary Tract Cancer | Phase 2 | Status: UNKNOWN